prof. dr. M. Koopman
Full Professor
- Department of Medical Oncology
Contact
Side Activities
Member of KWF scientific board, 2019-…
Chairman of the DCCG, 2019-...
CRC expert on Kanker.nl platform for answering online CRC questions of CRC (non) patients, 2018-...
ESMO faculty member for the Gastro-Intestinal Tumours, 2017-...
Member of the clinical advisory board of ONCODE, 2017-…
PI of the NWO gravitation program CancerGenomiCs.nl (CGC), 2017-.
Member of Utrecht Life Sciences (ULS) scientific board, 2017-…
Participant in the international collaboration of ARCAD (Aide et Recherche en Cancérologie Digestive). Advanced Colorectal Cancer Database, integrating patient-level data from most recent major trials in advanced colorectal cancer into a single resource, 2015-...
Member of the board Dutch population based cohort study for patients with colorectal Cancer, president of the executive committee, 2015-…
Research Output (139)
Mode of progression after radioembolization in patients with colorectal cancer liver metastases
van Roekel Caren, Jongen Jennifer M J, Smits Maarten L J, Elias Sjoerd G, Koopman Miriam, Kranenburg Onno, Borel Rinkes Inne H M, Lam Marnix G E H 22 sep 2020, In: EJNMMI Research. 10 , p. 107
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment
Derksen Jeroen W G, Warren Graham W, Jordan Karin, Rauh Stefan, Vera García Ruth, O'Mahony Deirdre, Ahmed Samreen, Vuylsteke Peter, Radulovic Sinisa, Tsoukalas Nikolaos, Wysocki Piotr J, Borner Markus, Cesas Alvydas, Elme Anneli, Minn Heikki, Ullenhag Gustav J, Roodhart Jeanine M L, Koopman Miriam, May Anne M 29 aug 2020, In: European Journal of Cancer. 138 , p. 99-108 10 p.
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE):study protocol for a trial within a cohort study
Schraa S J, van Rooijen K L, van der Kruijssen D E W, Rubio Alarcón C, Phallen J, Sausen M, Simmons J, Coupé V M H, van Grevenstein W M U, Elias S, Verkooijen H M, Laclé M M, Bosch L J W, van den Broek D, Meijer G A, Velculescu V E, Fijneman R J A, Vink G R, Koopman M, 20 aug 2020, In: BMC Cancer. 20 , p. 790
Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial):rationale and protocol of a single arm intervention study
van den Berg I, van de Weerd S, Roodhart J M L, Vink G R, van den Braak R R J Coebergh, Jimenez C R, Elias S G, van Vliet D, Koelink M, Hong E, van Grevenstein W M U, van Oijen M G H, Beets-Tan R G H, van Krieken J H J M, IJzermans J N M, Medema J P, Koopman M, 18 aug 2020, In: BMC Cancer. 20 , p. 776
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer:Secondary analysis of the phase 3 CAIRO3 trial
Kurk Sophie A, Peeters Petra H M, Dorresteijn Bram, de Jong Pim A, Jourdan Marion, Creemers Geert-Jan M, Erdkamp Frans L G, de Jongh Felix E, Kint Peter A M, Poppema Boelo J, Radema Sandra A, Simkens Lieke H J, Tanis Bea C, Tjin-A-Ton Manuel L R, Van Der Velden Ankie, Punt Cornelis J A, Koopman Miriam, May Anne M 18 dec 2019, In: Cancer Medicine. 9 , p. 1033-1043 11 p.
Taste and smell alterations (TSAs) in patients (pts) with stage II-III colon cancer (CC): A pilot within the PROTECT study
Derksen J. W. G., Koopman M., Huinink D. ten Bokkel, Sommeijer D. W., Dorresteijn B., Jourdan M., May A. M. okt 2019, In: Annals of Oncology. 30 , p. 735-735
Choosing the right strategy based on individualized treatment effect predictions: Combination versus sequential chemotherapy in patients with metastatic colorectal cancer
Koopman M., Kwakman J. J., van Kruijsdijk R. C. M., Elias S. G., Seymour M. T., Meade A. M., Visseren F., Punt C. J. A. okt 2019, In: Annals of Oncology. 30
Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients
Kurk Sophie A, Stellato Rebecca K, Peeters Petra H M, Dorresteijn Bram, Jourdan Marion, Oskam Marieke J, Punt Cornelis J A, Koopman Miriam, May Anne M 12 sep 2019, In: American Journal of Clinical Nutrition. 110 , p. 1395-1403 9 p.
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
Burzykowski Tomasz, Coart Elisabeth, Saad Everardo D, Shi Qian, Sommeijer Dirkje W, Bokemeyer Carsten, Díaz-Rubio Eduardo, Douillard Jean-Yves, Falcone Alfredo, Fuchs Charles S, Goldberg Richard M, Hecht J Randolph, Hoff Paulo M, Hurwitz Herbert, Kabbinavar Fairooz F, Koopman Miriam, Maughan Timothy S, Punt Cornelis J A, Saltz Leonard, Schmoll Hans-Joachim, Seymour Matthew T, Tebbutt Niall C, Tournigand Christophe, Van Cutsem Eric, de Gramont Aimery, Zalcberg John R, Buyse Marc, 4 sep 2019, In: JAMA network open. 2 , p. e1911750
The era of alternative designs to connect randomized clinical trials and real-world data
Derksen Jeroen W G, May Anne M, Koopman Miriam 11 jul 2019, In: Nature Reviews Clinical Oncology. 16 , p. 589 1 p.